Increased risk of bladder cancer with pioglitazone?
- 32 Downloads
- US Food and Drug Administration. FDA Drug Safety Communication: Updated FDA review concludes that use of type 2 diabetes medicine pioglitazone may be linked to an increased risk of bladder cancer. Internet Document : 12 Dec 2016. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm519616.htm
© Springer International Publishing Switzerland 2017